These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 12463140)

  • 21. New drug therapies for advanced renal cell carcinoma.
    Gore ME; Harrison ML; Montes A
    Expert Rev Anticancer Ther; 2007 Jan; 7(1):57-71. PubMed ID: 17187520
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cytoreductive nephrectomy in metastatic renal cell carcinoma: the evolving role of surgery in the era of molecular targeted therapy.
    Kwan KG; Kapoor A
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):157-65. PubMed ID: 19528804
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Healy KA; Marshall FF; Ogan K
    Expert Rev Anticancer Ther; 2006 Aug; 6(8):1295-304. PubMed ID: 16925495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current status of cytoreductive nephrectomy in metastatic renal cell carcinoma.
    Harshman LC; Srinivas S
    Expert Rev Anticancer Ther; 2007 Dec; 7(12):1749-61. PubMed ID: 18062749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Surgical treatment of adrenal metastasis from renal cell carcinoma: a single-centre experience of 45 patients.
    Antonelli A; Cozzoli A; Simeone C; Zani D; Zanotelli T; Portesi E; Cosciani Cunico S
    BJU Int; 2006 Mar; 97(3):505-8. PubMed ID: 16469016
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Treatment of advanced kidney cancer].
    Sack BI; Machsohn AN
    Z Urol Nephrol; 1981 Sep; 74(9):667-9. PubMed ID: 7314986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Are we really making an advance in the treatment of metastatic renal cell carcinoma?
    Kirkali Z
    Eur Urol; 2006 Apr; 49(4):604-5. PubMed ID: 16481098
    [No Abstract]   [Full Text] [Related]  

  • 28. [Progress and summary of recent congress: ASCO-GU, EAU, AUA, ASCO about the medical management of locally advanced or metastatic kidney cancer].
    Patard JJ; Escudier B; Paparel P; Neuzillet Y; Long JA; Baumert H; Correas JM; Lang H; Poissonnier L; Rioux-Leclercq N; Soulié M;
    Prog Urol; 2010 Mar; 20 Suppl 1():S11-5. PubMed ID: 20493436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No improvement in renal cell carcinoma survival: a population-based study in the Netherlands.
    Aben KK; Luth TK; Janssen-Heijnen ML; Mulders PF; Kiemeney LA; van Spronsen DJ
    Eur J Cancer; 2008 Aug; 44(12):1701-9. PubMed ID: 18502115
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Advances in immune-based therapies of renal cell carcinoma.
    Lam JS; Belldegrun AS; Figlin RA
    Expert Rev Anticancer Ther; 2004 Dec; 4(6):1081-96. PubMed ID: 15606335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Treatment of patients with metastatic renal cell cancer: a RAND Appropriateness Panel.
    Halbert RJ; Figlin RA; Atkins MB; Bernal M; Hutson TE; Uzzo RG; Bukowski RM; Khan KD; Wood CG; Dubois RW
    Cancer; 2006 Nov; 107(10):2375-83. PubMed ID: 17048248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Novel therapeutics for metastatic renal cell carcinoma.
    Hutson TE; Figlin RA
    Cancer; 2009 May; 115(10 Suppl):2361-7. PubMed ID: 19402059
    [TBL] [Abstract][Full Text] [Related]  

  • 33. C-reactive protein: a biomarker of survival in patients with metastatic renal cell carcinoma treated with subcutaneous interleukin-2 based immunotherapy.
    Casamassima A; Picciariello M; Quaranta M; Berardino R; Ranieri C; Paradiso A; Lorusso V; Guida M
    J Urol; 2005 Jan; 173(1):52-5. PubMed ID: 15592024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multidisciplinary treatment of brain metastases derived from clear cell renal cancer incorporating stereotactic radiosurgery.
    Samlowski WE; Majer M; Boucher KM; Shrieve AF; Dechet C; Jensen RL; Shrieve DC
    Cancer; 2008 Nov; 113(9):2539-48. PubMed ID: 18780316
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bilateral Wilms' tumors: a single-center experience with 19 cases.
    Millar AJ; Davidson A; Rode H; Numanoglu A; Hartley PS; Daubenton JD; Desai F
    J Pediatr Surg; 2005 Aug; 40(8):1289-94. PubMed ID: 16080934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel treatments for metastatic renal cell carcinoma.
    van Spronsen DJ; Mulders PF; De Mulder PH
    Crit Rev Oncol Hematol; 2005 Sep; 55(3):177-91. PubMed ID: 15979888
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II studies of antiangiogenic four drug regimens for the treatment of advanced renal cell carcinoma: FUNIL-retinoid and the FUNIL-thalidomide protocols.
    Pacheco AV; Rasila K; Lee SJ; Rabinowitz I; Elias L; Lee FC; Verschraegen CF
    Urol Oncol; 2008; 26(6):610-5. PubMed ID: 18367103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Laparoscopic versus open partial nephrectomy for the treatment of pathological T1N0M0 renal cell carcinoma: a 5-year survival rate.
    Permpongkosol S; Bagga HS; Romero FR; Sroka M; Jarrett TW; Kavoussi LR
    J Urol; 2006 Nov; 176(5):1984-8; discussion 1988-9. PubMed ID: 17070227
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The treatment of metastasized kidney cancer. Current data and perspectives].
    Desgrandchamps F; Cussenot O; Maréchal JM; Cortesse A; Teillac P; Le Duc A
    Prog Urol; 1993 Apr; 3(2):177-86. PubMed ID: 8508200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Treatment of renal carcinoma with metastases].
    Artibani W; Breda G; Zattoni F; Graziotti P; Vancini P; Mazza G
    Chir Ital; 1978 Apr; 30(2):81-105. PubMed ID: 350443
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.